VIR Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vir Biotechnology Inc

Watchlist Manager

Watchlist

Price: 10.88 USD 2.64% Market Closed

Market Cap: $1.8B

	Vir Biotechnology Inc NASDAQ:VIR	US
P	PharmaRoth Labs Inc OTC:ROTH	US
	L&T Finance Ltd NSE:LTF	IN
I	Italgas SpA F:I10	IT
	Wolters Kluwer NV F:WOS	NL
T	thyssenkrupp AG XMUN:TKA	DE
	Genmab A/S F:GE91	DK

Profitability Summary

Vir Biotechnology Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

98%

Gross Margin is Increasing

94% > 100%

Negative Operating Margin

-49%

Negative 3Y Average Operating Margin

-1 311%

Operating Margin is Increasing

-64% > -49%

Negative Net Margin

-42%

Negative 3Y Average Net Margin

-1 200%

Net Margin is Increasing

-53% > -42%

Negative Free Cash Flow Margin

-67%

Negative 3Y Average Free Cash Flow Margin

-1 102%

Free Cash Flow Margin is Increasing

-83% > -67%

Negative ROE

-13%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-116%

ROIC is Increasing

-75% > -24%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.